For example, NINJ1 has been shown to promote the formation and progression of non-small cell lung cancer (NSCLC) by protecting cancer stem cells from hostile microenvironments via the ligand-independent activation of the LRP6/β-catenin signaling pathway [12]. This evidence concerns the gene LRP6 and non-small cell lung carcinoma.